Pilot Trial of Supplemental Vitamin A and Nicotinamide
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to assess the feasibility and safety of oral nicotinamide
(NAM; a derivative of vitamin B3 [niacin]) and vitamin A in a high-risk population of kidney
transplant recipients with a history of skin cancer to generate preliminary data for future
cancer prevention clinical trials.
Phase:
Early Phase 1
Details
Lead Sponsor:
Rhode Island Hospital
Treatments:
Niacin Niacinamide Nicotinic Acids Vitamin A Vitamins